Schedule

The 45th Naito Conference

2018/06/26 (Tue.) - 06/29 (Fri.)

Conference Name	Immunological and Molecular Bases for Cancer Immunotherapy
Venue	CHATERAISE Gateaux Kingdom SAPPORO（Hokkaido）
Poster Application Period	2017/12/05（Tue.) - 2018/01/31 (Wed.)

To participate, presentation of poster relevant to the theme for the conference is mandatory.
The organizing committee will review and select 60 scientists as the poster presenters. Excellent poster presenters out of 60 will be awarded at the conference.

>> To submit abstract

Organizing Committee:

Kouji MATSUSHIMA (Chair): School of Medicine, The University of Tokyo, Japan
Kazuhiro KAKIMI: The University of Tokyo Hospital, Japan
Yutaka KAWAKAMI: Keio University School of Medicine, Japan
Hiroyoshi NISHIKAWA: National Cancer Center Research Institute, Japan
Heiichiro UDONO: Graduate School of Medicine, Okayama University, Japan

Plenary Lecturers:

Rafi AHMED: Emory Vaccine Center, Emory University, USA
Jedd D. WOLCHOK: Memorial Sloan Kettering Cancer Center, USA

Invited Lecturers:

Kenji CHAMOTO: Kyoto University Graduate School of Medicine, Japan
Greg M. DELGOFFE: University of Pittsburgh Cancer Institute Hillman Cancer Center, USA
Lawrence H. FONG: Helen Diller Family Comprehensive Cancer Center / University of California, San Francisco, USA
Shinichi HASHIMOTO: Graduate School of Medical Sciences, Kanazawa University, Japan
Naoki HOSEN: Graduate School of Medicine, Osaka University, Japan
Ira MELLMAN: Vice President, Genentech, Inc. USA
Hozumi MOTOHASHI: Institute of Development, Aging and Cancer, Tohoku University, Japan
Naoko OHTANI: Osaka City University Graduate School of Medicine, Japan
Shashank J. PATEL: National Cancer Institute, National Institutes of Health, NIH, USA
Antoni RIBAS: Department of Medicine, University of California Los Angeles, UCLA, USA
Ken-ichiro SEINO: Institute for Genetic Medicine, Hokkaido University, Japan
Tsukasa SEYA: Department of Microbiology and Immunology, Hokkaido University, Japan
Hiroshi SHIKU: Mie University Graduate School of Medicine / Center for Comprehensive Cancer Immunotherapy, Mie University, Japan
Stefani SPRANGER: David H. Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, MIT, USA
Koji TAMADA: Yamaguchi University Graduate School of Medicine
Masaki TERABE: Center for Cancer Research, National Cancer Institute, NIH, USA
Toshihiko TORIGOE: Sapporo Medical University School of Medicine, Japan
Zlatko TRAJANOSKI: Division of Bioinformatics, Medical University of Innsbruck, Austria
John WHERRY: Department of Microbiology, University of Pennsylvania, USA
Chenqi XU: Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, China

Sessions:

A：Immunological Basis ( 1 )
B：Immunological Basis ( 2 )
C：Immune and Cancer Metabolism
D：New Technologies in Cancer Research
E：Clinical Development of Cancer Immunotherapy

Return to TOP of this page